| Dr Christine Ibilibor, MD, MSC | |
|
500 Ray C. Hunt Dr, Charlottesville, VA 22903 | |
| (434) 924-9558 | |
| Not Available |
| Full Name | Dr Christine Ibilibor |
|---|---|
| Gender | Female |
| Speciality | Urology |
| Experience | 10 Years |
| Location | 500 Ray C. Hunt Dr, Charlottesville, Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417367855 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | BP10049568 (Texas) | Secondary |
| 208800000X | Urology | 0101272569 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Virginia Medical Center | Charlottesville, VA | Hospital |
| Shenandoah Memorial Hospital | Woodstock, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Virginia Physicians Group | 4880590728 | 1397 |
News Archive
Researchers at the University of Michigan Comprehensive Cancer Center have identified a genetic anomaly that may drive the aggressive spread of a rare subset of prostate cancers.
Accumulation of DNA damage can cause aggressive forms of cancer and accelerated aging, so the body's DNA repair mechanisms are normally key to good health. However, in some diseases the DNA repair machinery can become harmful.
The new Vital Signs report, released by the Centers for Disease Control and Prevention (CDC), has reported that of 250 pregnant women confirmed with Zika infection in 2016, approximately 1 in 10 of them had a fetus or infant with virus-related birth defects. Thisreport is the first of its kind, to present an analysis from a sample of US women with a definite case of Zika infection during pregnancy.
Gender matters when it comes to smoking cessation. Women are 31 percent less likely to quit smoking successfully, according to the National Institute of Drug Abuse, in part because nicotine replacement therapy is thought to be more effective in male smokers.
Gilead Sciences, Inc. today announced that Gilead and Teva Pharmaceuticals have reached an agreement in principle to settle the ongoing patent litigation concerning the patents protecting Viread (tenofovir disoproxil fumarate), a treatment for HIV infection and chronic hepatitis B. Under the terms of the settlement, Teva will be allowed to launch a generic version of Viread on December 15, 2017.
› Verified 7 days ago
| Entity Name | University Of Virginia Physicians Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033138250 PECOS PAC ID: 4880590728 Enrollment ID: O20040102000780 |
News Archive
Researchers at the University of Michigan Comprehensive Cancer Center have identified a genetic anomaly that may drive the aggressive spread of a rare subset of prostate cancers.
Accumulation of DNA damage can cause aggressive forms of cancer and accelerated aging, so the body's DNA repair mechanisms are normally key to good health. However, in some diseases the DNA repair machinery can become harmful.
The new Vital Signs report, released by the Centers for Disease Control and Prevention (CDC), has reported that of 250 pregnant women confirmed with Zika infection in 2016, approximately 1 in 10 of them had a fetus or infant with virus-related birth defects. Thisreport is the first of its kind, to present an analysis from a sample of US women with a definite case of Zika infection during pregnancy.
Gender matters when it comes to smoking cessation. Women are 31 percent less likely to quit smoking successfully, according to the National Institute of Drug Abuse, in part because nicotine replacement therapy is thought to be more effective in male smokers.
Gilead Sciences, Inc. today announced that Gilead and Teva Pharmaceuticals have reached an agreement in principle to settle the ongoing patent litigation concerning the patents protecting Viread (tenofovir disoproxil fumarate), a treatment for HIV infection and chronic hepatitis B. Under the terms of the settlement, Teva will be allowed to launch a generic version of Viread on December 15, 2017.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Christine Ibilibor, MD, MSC Po Box 800422, Charlottesville, VA 22908-0422 Ph: () - | Dr Christine Ibilibor, MD, MSC 500 Ray C. Hunt Dr, Charlottesville, VA 22903 Ph: (434) 924-9558 |
News Archive
Researchers at the University of Michigan Comprehensive Cancer Center have identified a genetic anomaly that may drive the aggressive spread of a rare subset of prostate cancers.
Accumulation of DNA damage can cause aggressive forms of cancer and accelerated aging, so the body's DNA repair mechanisms are normally key to good health. However, in some diseases the DNA repair machinery can become harmful.
The new Vital Signs report, released by the Centers for Disease Control and Prevention (CDC), has reported that of 250 pregnant women confirmed with Zika infection in 2016, approximately 1 in 10 of them had a fetus or infant with virus-related birth defects. Thisreport is the first of its kind, to present an analysis from a sample of US women with a definite case of Zika infection during pregnancy.
Gender matters when it comes to smoking cessation. Women are 31 percent less likely to quit smoking successfully, according to the National Institute of Drug Abuse, in part because nicotine replacement therapy is thought to be more effective in male smokers.
Gilead Sciences, Inc. today announced that Gilead and Teva Pharmaceuticals have reached an agreement in principle to settle the ongoing patent litigation concerning the patents protecting Viread (tenofovir disoproxil fumarate), a treatment for HIV infection and chronic hepatitis B. Under the terms of the settlement, Teva will be allowed to launch a generic version of Viread on December 15, 2017.
› Verified 7 days ago
Dr. Kirsten Greene, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 500 Ray C Hunt Dr, Charlottesville, VA 22903 Phone: 434-924-2224 Fax: 434-244-9481 | |
Mikel Gray, N.P. Urology Medicare: Accepting Medicare Assignments Practice Location: 500 Ray C Hunt Dr Fl 3, Charlottesville, VA 22903 Phone: 434-924-2224 Fax: 434-982-3652 | |
Jacqueline Marie Zillioux, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 500 Ray C Hunt Dr, Charlottesville, VA 22903 Phone: 434-924-2224 Fax: 434-244-9481 | |
Ryan P. Smith, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 500 Ray C Hunt Dr, Charlottesville, VA 22903 Phone: 434-924-2224 Fax: 434-982-3652 | |
Stephen H. Culp, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 500 Ray C Hunt Dr, Charlottesville, VA 22903 Phone: 434-924-2224 Fax: 434-244-9481 | |
Adel B. Guirguis, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: Uva Hospital W, Hospital Drive, Charlottesville, VA 22908 Phone: 434-924-2224 Fax: 434-243-6878 | |
Dr. Frazier T Fortenberry Jr., MD Urology Medicare: Accepting Medicare Assignments Practice Location: 630 Peter Jefferson Pkwy, Suite 135, Charlottesville, VA 22911 Phone: 434-244-5722 Fax: 434-244-5723 |